Items tagged with Treatment

“You see yourself vanishing and you think: I’m going to die” (post with simple image)

Andaleeb Rinquest remembers the moment she accepted, with certainty, the imminence of her own death.

Drug-resistant tuberculosis patients face dwindling treatment options (post with simple image)

Doctors believe there is greater drug resistance and complexity of TB, which disproportionally affects immigrants.

Latent TB: Shorter course of therapy effective in children (post with simple image)

In children with latent tuberculosis, 3 months of combined therapy with isoniazid and rifapentine is safe and as effective as 9 months of isoniazid alone.

Drug-resistant tuberculosis a tiny — but potent — foe in L.A. County (post with simple image)

Otsuka rejected Dr. Caitlin Reed’s attempt to obtain delamanid for her patient, Gary, who has the most drug-resistant case of TB ever identified in the United States.

Inside India: The deadly effects of red tape (post with simple image)

Red tape and over-regulation can kill.

Zimbabwe faces troubling spike in cases of multidrug-resistant TB (post with simple image)

HARARE, Jan 25 2015 (IPS) - About eight years ago, 44-year-old Tilda Chihota was struck with tuberculosis which kept her bed-ridden for over six months at her rural home in Zimbabwe’s Mwenezi district, 144 kilometres southwest of Masvingo, the country’s oldest town.

Phase 2a published results show the potential of a new TB regimen with novel drugs bedaquiline and pretomanid (PA-824) (post with simple image)

Results of study testing BPaZ published in American Journal of Respiratory and Critical Care Medicine; Regimen now being tested in Phase 2b clinical trial

TB Alliance advances next-generation TB drug candidate into clinical testing (post with simple image)

TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years.

Stop TB Partnership's Global Drug Facility (GDF) achieves historic price reduction for MDR-TB drug Cycloserine (post with simple image)

This price reduction is expected to save up to USD 22 million annually, enabling treatment for more people living with MDR-TB.

Call to action: Accelerate access to DR-TB drugs (post with simple image)

SIGN ON LETTER to global actors and drug companies: Please provide organizational sign-ons by 6 March.

Page 52 of 60 · Total posts: 0

←First 51 52 53 Last→